CJC-1295 (No DAC)
Short-Acting GHRH (1-29) Analog
CJC-1295 without Drug Affinity Complex is a tetrasubstituted GHRH(1-29) analog (also referred to as Mod-GRF 1-29). Engineered for resistance to dipeptidyl peptidase-IV cleavage, it exhibits a substantially shorter half-life than the DAC-conjugated variant. Studied in preclinical models of pulsatile GH secretion and somatotropic axis kinetics. For laboratory research use only.
Selectively agonizes the pituitary GHRH receptor, triggering cAMP-mediated GH release with rapid clearance that preserves natural pulsatility in research models.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
Mod-GRF (1-29) — tetrasubstituted GHRH(1-29) analog, no DAC.
Every batch of CJC-1295 (No DAC) ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
